Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological CancerTumor Infiltrating LymphocytesNot yet recruitingPhase 1 / Phase 22021-12-10NCT05152797

4 results · Page 1 of 1

Swipe the table sideways for more columns.

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
No products are listed yet.